Home > Press > Nanotechnology’s risks can be addressed responsibly today
Abstract:
Lux Research report finds that more nano-enabled products are exposed to perceived risks than real ones
Stakeholders ranging from corporations to start-ups to protest groups are concerned about the environmental, health, and safety (EHS) risks of nanoparticles – the prospect that tiny, engineered particles of matter might harm workers, consumers or the environment. While such EHS risks do exist, they can be appropriately addressed today using well-established risk management techniques, according to a new report from Lux Research entitled “A Prudent Approach to Nanotech Environmental, Health, and Safety Risks.”
“If definitive data was available about the toxicity and environmental impact of nanoparticles, there would be no debate,” said Lux Research Vice President of Research Matthew M. Nordan. “However, today fundamental research in the field is just getting underway. Lab-based studies are thin on the ground, and those that have been published sometimes conflict. We recommend that corporations and start-ups assess nanotech EHS issues based on existing risk management frameworks – substituting informed, conservative proxies for definitive data – to make wise commercialization decisions.”
To build a framework for assessing nanotech EHS risks, Lux Research conducted exhaustive secondary research on the issue and interviewed 42 relevant start-up executives, academics, government agency representatives, non-governmental organization representatives, insurance company executives, and corporate EHS officers. The report finds that:
The report finds that nanotech EHS risks require specific actions from corporations, start-ups, investors, and governments to address. Corporations and start-ups should consider the full lifecycle of nanoparticles in the products they go into, focus on communicating nanotech’s benefits to consumers as well as risks, and work together to execute fundamental toxicity studies early in application development. Investors should incorporate EHS risks into their valuations of nanotech start-ups and publicly traded companies, affording them the same priority as the strength of the company’s management team or intellectual property.
“Ultimately, governments are accountable for ensuring that applications of nanoparticles are developed responsibly,” said Nordan. “We believe that funding levels for nanotech EHS research must be substantially increased to between two and four times today’s spending; only 3.7% of the $1.05 billion U.S. National Nanotechnology Initiative budget for 2006 is earmarked for EHS issues. Further, governments must wield their influence to coordinate today’s globally splintered nanotech EHS initiatives, and set clear expectations for industry as to how they plan to regulate nanoparticles. There is evidence that regulatory ambiguity is beginning to slow commercialization.”
The report provides decision tools that assess the likely EHS risks of ten categories of nanomaterials across ten target applications. The full report is available immediately to clients of Lux Research’s Nanotechnology Strategies advisory service. For information on how to become a client, contact Rob Burns, Vice President of Sales, at (646) 723-0708. An executive summary of the report is available at www.luxresearchinc.com
About Lux Research:
Lux Research is the world's leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts' unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.
To get connected and for more information, visit www.luxresearchinc.com
For early registration and event details for the Lux Executive Summit, please visit www.luxexecutivesummit.com
Contact:
Rob Burns
Vice President of Sales
(646) 723-0708
Copyright © Lux Research
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Ethics
Artificial Intelligence Centered Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics June 3rd, 2022
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016
Synthetic biology needs robust safety mechanisms before real world application: Ethics and technology hold the key to the success of synthetic biology September 17th, 2015
March 2016; 6th Int'l Conference on Nanostructures in Iran July 29th, 2015
Preparing for Nano
Disruptive by Design: Nano Now February 1st, 2019
How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016
Searching for a nanotech self-organizing principle May 1st, 2016
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Environment
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
New method in the fight against forever chemicals September 13th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||